Willamette Valley Clinical studies

Eugene, Oregon 97404

1 studies enrolling now · 19 studies all time

What they study most

COVID-19, Combined Hyperlipidemia, Cortisol Excess, Diabetes Mellitus, Type 2, Dyslipidemia, Essential Hypertension, Hyperlipidemia, Hypertension, Low Back Pain, Major Depressive Disorder, Renal Insufficiency, Resistant Hypertension

Studies at this site

• Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) — Recruiting now
• Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension — Running, not enrolling
• A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus — Completed
• A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir — Completed
• A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety — Completed
• An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets — Completed
• Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension — Completed
• Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD) — Completed
• Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study) — Completed
• Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency — Completed
• Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM — Completed
• A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia — Completed
• Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication — Completed
• Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia — Status unconfirmed
• Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain — Completed
• The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects — Completed
• Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia — Stopped early